Sainaghi PP - Search Results

1

Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors.

Apostolo D, D'Onghia D, Tonello S, Minisini R, Baricich A, Gramaglia C, Patrucco F, Zeppegno P, Acquaviva A, Balbo PE, Castello LM, Cappellano G, Chiocchetti A, Gerevini C, Giordano M, Laaguid F, Manfredi M, Raineri D, Rigamonti C, Rolla R, Romano V, Confalonieri M, Savoia P, Zavattaro E, Pirisi M, Ruaro B, Sainaghi PP, Bellan M; No-More COVID Group. Apostolo D, et al. Among authors: sainaghi pp. Int J Mol Sci. 2023 Mar 26;24(7):6257. doi: 10.3390/ijms24076257. Int J Mol Sci. 2023. PMID: 37047229 Free PMC article.

2

[Diagnosis and therapy of hyponatremia].

Bartoli E, Castello L, Sainaghi PP. Bartoli E, et al. Among authors: sainaghi pp. Ann Ital Med Int. 2003 Oct-Dec;18(4):193-203. Ann Ital Med Int. 2003. PMID: 14971708 Review. Italian.

3

Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor.

Sainaghi PP, Castello L, Bergamasco L, Galletti M, Bellosta P, Avanzi GC. Sainaghi PP, et al. J Cell Physiol. 2005 Jul;204(1):36-44. doi: 10.1002/jcp.20265. J Cell Physiol. 2005. PMID: 15605394

4

Hyponatremia in liver cirrhosis: pathophysiological principles of management.

Castello L, Pirisi M, Sainaghi PP, Bartoli E. Castello L, et al. Among authors: sainaghi pp. Dig Liver Dis. 2005 Feb;37(2):73-81. doi: 10.1016/j.dld.2004.09.012. Dig Liver Dis. 2005. PMID: 15733516 Review.

5

Quantitative treatment of the hyponatremia of cirrhosis.

Castello L, Pirisi M, Sainaghi PP, Bartoli E. Castello L, et al. Among authors: sainaghi pp. Dig Liver Dis. 2005 Mar;37(3):176-80. doi: 10.1016/j.dld.2004.10.008. Epub 2004 Dec 15. Dig Liver Dis. 2005. PMID: 15888282

6

Comparison between HOMA-IR and ISI-gly in detecting subjects with the metabolic syndrome.

Carnevale Schianca GP, Sainaghi PP, Castello L, Rapetti R, Limoncini AM, Bartoli E. Carnevale Schianca GP, et al. Among authors: sainaghi pp. Diabetes Metab Res Rev. 2006 Mar-Apr;22(2):111-7. doi: 10.1002/dmrr.560. Diabetes Metab Res Rev. 2006. PMID: 16052601

7

Progression from hidden to overt type 2 diabetes mellitus: significance of screening and importance of the laboratory.

Bartoli E, Castello L, Sainaghi PP, Schianca GP. Bartoli E, et al. Among authors: sainaghi pp. Clin Lab. 2005;51(11-12):613-24. Clin Lab. 2005. PMID: 16329619 Review. No abstract available.

8

Pathways of glomerular toxicity of cyclosporine-A: an "in vitro" study.

Castello L, Sainaghi PP, Bergamasco L, Letizia C, Bartoli E. Castello L, et al. Among authors: sainaghi pp. J Physiol Pharmacol. 2005 Dec;56(4):649-60. J Physiol Pharmacol. 2005. PMID: 16391421 Free article.

9

A malignant fibroleiomyoma of the testis.

Avanzi GC, Castello L, Sainaghi PP, Bergamasco L, Boldorini R, Bartoli E. Avanzi GC, et al. Among authors: sainaghi pp. Clin Lymphoma Myeloma. 2006 Mar;6(5):414-6. doi: 10.3816/CLM.2006.n.021. Clin Lymphoma Myeloma. 2006. PMID: 16640821

10

Poor specificity of fasting plasma glucose cut-off values in ruling out glucose intolerance: the complementary usefulness of OGTT.

Sainaghi PP, Castello L, Limoncini AM, Bergamasco L, Bartoli E, Schianca GP. Sainaghi PP, et al. Exp Clin Endocrinol Diabetes. 2007 Feb;115(2):112-7. doi: 10.1055/s-2007-949151. Exp Clin Endocrinol Diabetes. 2007. PMID: 17318771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page